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Testing Hair for Illicit Drug Use 
The rising popularity of cocaine since the 
mid-1980's gave new urgency to the long-
standing interest in developing accurate 
ways to measure the incidence and preva-
lence of drug use. Accurate estimates of 
drug trends within an offender population 
are critical in the development of public 
policy and the efficient use of limited 
criminal justice resources. 
To this end, a National Institute of Justice 
(NIJ) study among arrestees in an urban 
county jail compared tests of hair for signs 
of drugs of abuse with testing by urinalysis 
and with self-reports of drug use. The 
study also considered how applicable hair 
testing might be for monitoring the drug 
status of offenders. The study's results are 
summarized in this Research in Brief 
Monitoring offenders' 
drug use 
At a variety of criminal justice system 
levels, monitoring the drug status of of-
fenders is of considerable importance. 
Indeed, the use of drug monitoring to help 
From the Director 
Testing for drug use is an essential element 
in the Nation's battle against drug abuse and 
drug-related crime. The Drug Use Forecast-
ing (DUF) program established by the Na-
tional Institute of Justice (NIJ) in 1987 relies 
upon urinalysis, a recognized indicator of 
drug use. 
NIJ is seeking alternative techniques with 
complementary capabilities to strengthen 
detection and control of drug use. Hair test-
ing may provide wider windows of detection 
and less opportunity for evasion. 
by Tom Mieczkowski, Harvey J. Landress, 
Richard Newel, and Shirley D. Coletti 
determine particular criminal dispositions 
is already established in many local justice 
agencies,' and a person's drug use patterns 
and history often inform decisions related 
to placement, release and surveillance, and 
mandatory referral to treatment. 
Urinalysis testing 
Self-reported drug use has been the most 
widely used source of drug use data for the 
past three decades,2 but since the early 
1970's and the development of reliable and 
inexpensive immunoassay technology, 
urinalysis screening has become an impor-
tant tool. Systems such as NIJ's Drug Use 
Forecasting (DUF) program, cofunded 
by the Bureau of Justice Assistance, 
proved the utility of urinalysis in acquiring 
accurate data among a criminal justice 
population. 
Immunoassay technology, whether based 
on radioisotopes, enzymes, or fluores-
cence, enhanced our ability to measure 
illicit drug use. However, use of urine as 
the test medium imposes practicallimita-
Hair analysis offers unique advantages com-
pared to other currently used drug testing 
methods. Hair retains drug components for 
longer periods, and drug use can be detected 
in hair for weeks or even months compared to 
the 2 to 3 days that cocaine or heroin can be 
detected in blood or urine. 
As this Research in Bri~f'points out, hair 
analysis also offers other advantages over 
other testing methods: for example, hair 
specimens can be readily obtained without the 
privacy problems associated with obtaining 
tions on the frequency of collection when 
these techniques are applied. Opiates and 
cocaine are water-soluble and quite rapidly 
excreted, generally within 48 to 72 hours. 
Only marijuana, which is fat-soluble, has a 
slow, relatively long-term urine excretion 
rate (regular, heavy users can test positive 
for several weeks). 
These characteristics suggest that urine-
based data on cocaine and opiate use, 
derived from a single urine test, underesti-
mate the true extent of opiate and cocaine 
use. 
Use of hair testing 
Use of hair as a test medium avoids the 
limitations of infrequent urine testing. Hair 
testing is relatively well established and 
uses a number of the same technologies as 
urine-based tests, including enzyme, radio-
isotope, and fluorescent immunoassays. 
The methodologies are identical; the dis-
tinction is in the medium. 
Hair has several advantages over urine in 
testing for drugs of abuse: 
urine specimens or the invasiveness of draw-
ing blood. 
NIJ is currently conducting research into the 
effectiveness of the use of hair analysis, ef-
forts that wi II explore the costs and opera-
tional issues involved in implementing this 
drug testing method in probation and parole 
settings. 
Charles B. DeWitt 
Director 
National Institute of Justice 
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Testing hair for illicit 
drug use 
• Hair greatly expands the time window 
for the detection of an illicit drug. Urinaly-
sis of a single specimen generally can de-
tect the presence of drugs for a period of 
several days to a week or two, depending 
on the drug. Hair analysis can detect drug 
use for several months or more, depending 
on the length of the hair. 
• Brief periods of abstinence from drugs 
will not significantly alter the outcome of 
hair analysis. 
• Hair is relatively inert, easy to handle, 
and requires no special storage facilities 
or conditions. Compared with urine 
samples, it presents fewer risks of disease 
transmission. 
• Having some hair snipped from the 
head is less invasive and embarrassing for 
most people than supplying a monitored 
urine specimen. 
• Collecting comparable samples for re-
peat testing is easier with hair than with 
urine. 
• Contaminating or altering a sample to 
distort or manipulate test results is much 
more difficult with hair than with urine. 
Preliminary research shows that even 
treating hair with a variety of strong com-
pounds will not completely eliminate 
traces of illicit drugs. 
Scientific basis 
for hair testing 
Scientifically, the radioimmunoassay of 
hair (RIAH) rests on the fact that growing 
hair absorbs drugs and their metabolites 
into its structure from the circulatory sys-
tem. Metabolites are the biochemical prod-
ucts of the breakdown of drugs within the 
body. For cocaine, both urine testing and 
hair testing detect the drug metabolites 
rather than the illegal drug itself.1 
Once a drug metabolite is embedded in the 
hair shaft, a process which appears to 
occur while the hair is being formed in its 
follicle, the metabolite is very nearly per-
manent. As the hair shaft grows, it forms a 
longitudinal record of the compounds it 
has absorbed, including drugs of abuse. 
Drug metabolites appear in detectable 
levels in hair approximately a week after 
ingestion.4 Hair grows at an average rate 
of about half an inch every 30 days. The 
hair shaft can be cut into various lengths, 
allowing a "time line" analysis of drug 
consumption. Like a tape recording, a hair 
specimen can allow an analyst to construct 
a history of drug use. This "tape recording" 
presents an expanded time-monitoring 
window in contrast to single urine speci-
mens collected at widely spaced intervals. 
Additional research is needed to better 
understand such issues as the biochemical 
processes of the absorption of drugs and 
their metabolites into hair, dose-related 
cutoff levels, and the influence of external 
contamination. NIJ is currently conducting 
studies on these issues. 
The Pinellas County project 
Pinellas County (population 851 ,000), 
located on Florida's West Central coast, is 
Exhibit 1. Number of Arrestees, by Charge 
Drug sale, possession 70 
Driving intoxicated 51 
Larceny 36 
Burglary 35 
Assault 17 
Fraud 16 
Forgery 10 
Auto theft 1 0 
Robbery 8 
Stolen property 6 
Sex offense 5 
VVeapons 5 
Manslaughter 
Arson 
Family offense 
Homicide 
Prostitution 
Damaged property 
Embezzlement 
Kidnaping 
Resisting arrest 
Rape 
Other 
Total 
4 
3 
3 
1 
1 
1 
1 
1 
1 
1 
17 
303 
2 
the most highly urbanized and densely 
populated county in Florida. In fall 1989, 
officials from a local drug treatment pro-
vider (Operation PAR), the Pinellas 
County Sheriff's Office, and a researcher 
from the University of South Florida con-
ducted a research project to (I) compare 
the results of hair testing, urinalysis, and 
self-reports of drug use among arrestees at 
the Pinellas County Jail, and (2) evaluate 
the implementation and utility of a hair-
based drug monitoring system. 
Funded by NIJ and the Pinellas County 
Sheriff's Department, the project was 
similar to NIJ's DUF program, and the 
method was essentially the same. Recent 
arrestees agreed to anonymous interviews 
and were tested for evidence of recent drug 
use. Using a modified DUF questionnaire, 
the project gathered self-reported drug-use 
data. Urine specimens were collected and 
analyzed. The research staff also collected 
hair samples from the arrestees and 
had those samples tested, using RIAH 
technology. 
Between 250 and 300 arrestees who met 
the general eligibility conditions of the 
national DUF protocol ..vere interviewed at 
the time of booking. Anyone arrested more 
than 24 hours before contact with the inter-
viewer was excluded from the sample. In 
Pinellas, drug arrests constituted about 23 
percent of the sample. Pinellas also in-
cluded offenders brought in on drunk 
driving charges (DUI or DWI). Exhibit I 
provides a breakdown by type of crime 
for which those in the sample had been 
arrested. 
The sample size and composition along 
with rates of donating both hair and urine 
are summarized in exhibit 2. 
Findings 
Exhibit 3 compares the positive outcomes 
of hair analysis, urine testing, and self-
reports by drug tested. The data show that 
the number of arrestees who self-reported 
they used cocaine or opiates within the 
past 30 days was not much greater than 
those who reported use within the past 48 
hours. Both hair testing and urinalysis 
produced a larger number of positive re-
sults than did self-reports; more signifi-
cantly, however, there was a substantially 
·a- ~reater proportion of positive hair assays 
than positive urine samples.* 
Overall, the findings are consistent with 
the literature of recent years correlating 
self-reported drug use and the outcome of 
urine testing for drugs of abuse. One con-
sistently finds patterns among arrestees 
of underreporting of personal drug use. 5 
Other main findings can be summarized as 
follows: 
• There were about four times more posi-
tive hair test results for cocaine than for 
self-reported use within the previous 30 
days (46.5 percent vs. 11.2 percent). 
e There were more than twice the number 
of positive hair test results for cocaine than 
positive urine tests ( 46.5 percent vs. 20.4 
percent). 
• There were 5 l/2 times more positive 
hair test results for cocaine than for self-
reported use within the previous 48 hours 
(46.5 percent vs. 8.3 percent). 
• There were 2 1/2 times more positive 
urine test results for cocaine than for 
self-reported use within the previous 48 
'Iours (20.4 percent vs. 8.3 percent). 
I 
• There were nearly nine times more 
positive hair test results for opiates than for 
self-reported use within the previous 30 
days (8.9 percent vs. 1 percent). 
The outcomes for self-reports and one-time 
urinalysis testing display a clear pattern of 
underreporting. However, comparing 
urinalysis results to self-reported use 
within the previous 30 days reveals a rela-
tively smaller amount of discrepancy. 
In addition to urinalysis testing conducted 
by EMITfM (enzyme multiplied immuno-
assay technique), urinalysis was conducted 
by a second method, fluorescence polariza-
tion immunoassay (FPIA). The analysis 
shown in exhibit 4 measured how EMIT 
and FPIA results compared with hair test 
results. 
A total of256 specimens were analyzed by 
radioimmunoassay of hair, and by EMIT 
and FPIA for urine. Ofthese, 153 had the 
same test result, whether positive or nega-
tive, when tested by RIAH, EMIT, and 
' This finding must be qualified. The hair 
samples were not assayed for marijuana be-
cause not enough hair was obtained to conduct 
assays for all desired tests. 
Exhibit 2. Sample Composition and Donation Rate 
Gave urine Gave hair 
Yes No Yes No 
White 210 13 219 4 
Race Black 63 12 69 6 Hispanic 3 0 3 0 
Other 2 0 2 0 
Sex Male 253 21 266 8 
Female 25 4 27 2 
Total (n = 303) 278 25 293 10 
Exhibit 3. Comparisons of Positive Outcomes: Self-reports, Urinalysis, and 
Hair Analysis (n = 303) 
Self-reported drug use Assay results 
Have you used in prior 48 hours in prior 30 days Urine(+) Hair(+) 
Any cocaine? 25 (8.3%) 
Opiates? 0 (0.0%) 
Marijuana? 47 (15.5%) 
FPIA. The most important result is that 88 
of the 256 specimens analyzed for opiates 
and cocaine were identified as drug posi-
tive by RIAH but negative by both urine 
testing techniques. 
Of these 88 specimens, confirmatory test-
ing was completed on 9 (10 percent) using 
a very accurate but expensive technique: 
gas chromatography/mass spectrometry 
(GC/MS). Budgetary constraints and hair 
specimen sizes precluded further confirma-
tion tests. However, even though these 
tests used only the remaining portions of 
the hair samples, GC/MS detected cocaine 
in all nine specimens, indicating RIAH's 
potential to identify individuals who may 
be drug users but who probably have not 
taken drugs within a day or two of a urine 
test. 
Seven specimens were positive by RIAH 
as well as by one of the two urine test 
methods. This difference is probably due 
to one of the urine tests being a "false-
negative" result; that is, the drug metabo-
lite was not present in sufficient quantity to 
be reliably identified as a drug-positive 
specimen. 
3 
34 
3 
94 
(11.2%) 62 (20.4%) 141 (46.5%) 
(1.0%) 5 (1.7%) 27 (8.9%) 
(31.0%) 120 (39.6%) n/a 
Two specimens were negative by RIAH 
and negative on one of the urine tests but 
positive on another. This indicates a "false-
positive" urine result; that is, the test result 
is reported as positive even though a drug 
metabolite is not truly present.t 
Quantitative analysis 
The laboratory that tested the hair samples 
developed a tentative scale that categorizes 
specimen results into six groups based on 
the level of drug detected. In this "Psyche-
medics Scale," Group I RIAH results are 
the lowest detected level of an assayed 
drug, while Group 6 is the highest level. 
Group 0, no drug detected, is not reported 
here. Exhibit 5 shows the distribution of 
cocaine positive urine assays by FPIA and 
t The data most difficult to explain are those 
that show 6 of 256 specimens (2.4 percent) 
negative by RIAH but positive by both urine-
test methods. While there are several possible 
explanations, including the possibility that 
these were casual users, additional research is 
needed to explore the anomaly. 
Exhibit 4. Comparison of Urine and Hair Test Results for Opiates and 
Cocaine (n = 256) 
Urine results by FPIA and EMIT 
Both positive ( +) 
Both negative(-) 
One positive(+) and one negative(-) 
Hair test results 
(+) 
40 
88 
7 
(-) 
6 
113 
2 
Exhibit 5. Distribution of Hair and Urine Assays Positive for Cocaine and 
Self-reported Cocaine Use, Grouped by Psychemedics Scale 
35 
30 • FPIA (+)of urine RIAH (+)of hair 
D Self-reported use in 30 days 
U) 25 Cl) 
U) 
(U 
0 
-
20 0 
.... 
Cl) 
.a 
E 15 
::::J 
z 
10 
5 
0 
Group 1 Group 2 Group 3 Group 4 Group 5 Group 6 
Cocaine Self-reported, or(+) in Specimen Assay 
Example: Of the 35 persons testing hair(+), in Group 1, 3 of them were also(+) 
by urinalysis and 2 self-reported cocaine use. 
Note: Group 1 has the lowest detected level by radioimmunoassay of hair (RIAH). 
Group 6 has the highest detected levels. 
Group 0 (none detected) is not shown. 
self-reported cocaine use grouped by the 
Psychemedics Scale. 
At low levels of cocaine use (Groups I and 
2), RIAH appears to detect about I 0 times 
as many drug users as urinalysis, based on 
currently accepted cutoff levels. Thus, a 
single hair test appears to have the poten-
tial of identifying many more drug users 
than would otherwise become known by a 
single urine screen. 
At comparable levels, urinalysis tech-
niques cannot differentiate between users 
who have recently consumed very small 
amounts of a drug and those who have 
consumed significant amounts but have 
had a more than 2- or 3-day lapse between 
ingestion and testing. 
At moderate levels of cocaine use (Groups 
3 and 4), RIAH appears to detect three to 
4 
four tim s as many users as urinalysis. As 1( 
the in ten. ity of cocaine use rises, RIAH ' 
and FPIA urinalysis values come into close 
alignment, with negligible differences 
between them. This makes intuitive sense. 
Daily or near-daily users would likely be 
detected by any assay method, inasmuch as 
such users are virtually always excreting 
the drug or its metabolites. 
Among the criteria used by the laboratory 
to assign each specimen an intensity-of-use 
scale number, the staff included judgments 
that reflected the extent to which the hair 
sample had been previously treated by 
commercial hair products. For this reason, 
the group numbers assigned reflect not 
only rigid cutoffs in nanograms per 10 
milligrams of hair, but also the clinical 
judgments of the laboratory staff . 
Conclusions 
Radioimmunoassay of a single hair speci-
men detects more drug exposure than is 
self-reported or detected by a single urine 
test. The degree of this underreporting 
appears to vary to some extent with the 
type of drug. These research findings are ( 
most relevant for cocaine: It was detected 
in a r~latively large number of subjects, 
and three disparate types of data-self-
report, urinalysis, and RIAH-were avail-
able. Although more work must be done 
in establishing standard protocols and 
procedures for using RIAH as a routine 
screening device, sufficient information is 
available to support the utility of hair test-
ing for detecting drugs of abuse. 
Hair testing appears to have a number of 
advantages, including its less invasive 
method of collection, the extended time 
window of results, the stability of the me-
dium, and the difficulty of tampering with 
the medium to evade positive test results. 
Some practical difficulties may occur in 
collecting specimens from individuals with 
short or no head hair. 
RIAH's applicability in the monitoring of 
offender drug use may very likely permit a 
better determination of drug exposure over 
longer timeframes than is currently avail-
able using urine screening methods con-
ducted less than twice a week. In fact, 
hair-based testing could be conducted with 
less frequency than would be required in 
order to achieve a comparable level of 
confidence with urinalysis testing. 
~inally, hair testing appears to hold prom-
\ fse as a useful tool in dmg epidemiology. 
Yet, a substantial amount of field testing is 
still required before it attains the degree of 
acceptance now accorded urinalysis test-
ing. Nevertheless, the outcome of this 
project indicates that such testing ought 
to continue. 
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